Newsfeeds - Spark Newswire

2 minute read

News

Wave Life Sciences Reports Amendment To Central Nervous System Collab With Takeda: Allows For Co. To Advance, Partner On Its Central Nervous System Programs

Today, 2:54 AM

Amendment to ongoing collaboration allows Wave to advance or partner CNS programs, including those using ADAR editing Takeda option to co-develop and co-commercialize late-stage CNS programs, including clinical programs

WVE

2 minute read

News

Wave Life Sciences Reports Amendment To Central Nervous System Collab With Takeda: Allows For Co. To Advance, Partner On Its Central Nervous System Programs

By 8

Today, 2:54 AM

WVE

5 minute read

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer’s Sleep Disorder Drug Filing Accepted For Review, Voyager’s Licensing Options Deal

By Shanthi Rexaline

Today, 2:54 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5)

ABEO

6 minute read

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout

By Shanthi Rexaline

Today, 2:54 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4)

ADTX

4 minute read

48 Biggest Movers From Yesterday

By Lisa Levin

Today, 2:54 AM

Gainers Gogo Inc. (NASDAQ: GOGO) shares climbed 37.6% to close at $16.82 on Tuesday after the company raised the long-term financial targets announced during Q4 2020 earnings.

ABVC

1 minute read

Wave Life Sciences Announces New Data For Leading RNA Editing Capability Across Multiple Tissues, Provides Update On AATD Program During Analyst And Investor Research Webcast

By Benzinga Newsdesk

Today, 2:54 AM

Wave Life Sciences Ltd. (NASDAQ:WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, today presented new data for its ADAR-mediated

WVE

1 minute read

Events
News

Wave Life Sciences To Present At Chardan Genetic Medicines Conference Monday, Oct. 4, 2021 At 2 p.m. EDT

By Benzinga Newsdesk

Today, 2:54 AM

WVE

1 minute read

WAVE Life Sciences, Seelos Therapeutics Shares Up ~11% Following Earlier STAT News Article ‘Facing pressure from ALS patients and advocates, the FDA does about-face on review of potential treatment’

By Benzinga Newsdesk

Today, 2:54 AM

https://www.statnews.com/2021/09/15/facing-pressure-from-als-patients-and-advocates-the-fda-does-about-face-on-review-of-potential-treatment/

SEEL

1 minute read

Wave Life Sciences Sponsored Study Titled ‘Study of WVE-003 in Patients With Huntington’s Disease’ Posted To ClinicalTrials.gov; Shows Study Is Recruiting

By Michael Horton

Today, 2:54 AM

https://clinicaltrials.gov/ct2/show/NCT05032196

WVE

1 minute read

WAVE Life Sciences Q2 EPS $(0.78) Misses $(0.64) Estimate, Sales $2.78M Down From $3.03M YoY

By Benzinga Newsdesk

Today, 2:54 AM

WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(0.78) per share which missed the analyst consensus estimate of $(0.64) by 21.88 percent. This is a 32.17 percent increase over losses of $(1.15) per share

WVE